Conditions : Mucopolysaccharidosis IV A; Morquio A Syndrome; MPS IVA Intervention : Drug: BMN 110 Sponsor : BioMarin Pharmaceutical Enrolling by invitation - verified August 2011

Conditions : Neurofibromatosis Type 1; Plexiform Neurofibroma; Neurofibromatoses Intervention : Drug: RAD001: Everolimus Sponsors : Assistance Publique - Hôpitaux de Paris; Novartis Recruiting - verif...

Condition : Acromegaly Intervention : Drug: Active oral octreotide study drug therapy Sponsor : Chiasma, Inc. Not yet recruiting - verified August 2011

Condition : Acromegaly Intervention : Drug: Active oral octreotide study drug therapy Sponsor : Chiasma, Inc. Not yet recruiting - verified August 2011

Condition : Osteogenesis Imperfecta Interventions : Drug: BPS804; Other: Untreated reference group Sponsor : Novartis Pharmaceuticals Recruiting - verified August 2011

Conditions : Bone Metastases in Men With Hormone-Refractory Prostate Cancer; Bone Metastases in Subjects With Advanced Breast Cancer Intervention : Drug: denosumab Sponsor : Amgen Enrolling by invitat...

Condition : Osteochondritis Dissecans Intervention : Device: Biphasic osteochondral composite Sponsor : National Taiwan University Hospital Recruiting - verified August 2011

Condition : Osteochondritis Dissecans Intervention : Device: Biphasic osteochondral composite Sponsor : National Taiwan University Hospital Recruiting - verified August 2011

Condition : Neurofibromatosis Type 1 Intervention : Sponsor : Washington University School of Medicine Recruiting - verified August 2011

Condition : Vertebral Bony Metastases Intervention : Other: exercise Sponsors : University of Heidelberg; Dept of Radiation Oncology, University of Heidelberg, Germany Not yet recruiting - verified Au...